Charles Schwab Investment Management Inc. boosted its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 18.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,443,713 shares of the health services provider’s stock after purchasing an additional 384,528 shares during the period. Charles Schwab Investment Management Inc. owned about 1.42% of Teladoc Health worth $22,213,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Whipplewood Advisors LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth approximately $29,000. Versant Capital Management Inc grew its holdings in shares of Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the period. KBC Group NV grew its holdings in shares of Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock worth $80,000 after acquiring an additional 3,714 shares during the period. Westside Investment Management Inc. grew its holdings in shares of Teladoc Health by 43.8% during the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after acquiring an additional 2,800 shares during the period. Finally, GSA Capital Partners LLP purchased a new position in shares of Teladoc Health during the 3rd quarter worth approximately $92,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Analyst Ratings Changes
TDOC has been the topic of a number of research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research note on Monday, March 3rd. Piper Sandler cut their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Finally, Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $11.26.
Teladoc Health Price Performance
NYSE TDOC opened at $8.40 on Wednesday. The business’s fifty day moving average price is $10.51 and its 200-day moving average price is $9.74. The stock has a market capitalization of $1.46 billion, a price-to-earnings ratio of -1.46 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a 1-year low of $6.76 and a 1-year high of $15.68.
Teladoc Health (NYSE:TDOC – Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.
Teladoc Health Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
See Also
- Five stocks we like better than Teladoc Health
- 3 Warren Buffett Stocks to Buy Now
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Best Stocks Under $5.00
- 3 Must-Own Stocks to Build Wealth This Decade
- 3 REITs to Buy and Hold for the Long Term
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.